NEU 3.32% $20.52 neuren pharmaceuticals limited

Share Price, page-10857

  1. 2,634 Posts.
    lightbulb Created with Sketch. 142
    RSRT failed to mention that 95% of participants elected to continue in the LILAC open label extension study. Why would that be the case if the results were so poor according to RSRT anyway. You can see their staff and board on their website, along with their potential interests by looking at their linkedin profiles
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.